# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1694363 | F | Induction of NRF2/ARE enhancer activity rat PC12 cells transfected with ARE-firefly luciferase reporter gene at 10 uM after 24 hrs by luciferase assay | Rattus norvegicus | 8 | cell-based format | Scientific Literature | ||
2. | ALA3090682 | F | Increase in 2-NBDG uptake in mouse 3T3L1 cells after 30 mins by fluorescence spectrophotometry | Mus musculus | 4 | cell-based format | Scientific Literature | ||
3. | ALA3090683 | F | Increase in 2-NBDG uptake in mouse 3T3L1 cells at 400 ug/ml after 30 mins by fluorescence spectrophotometry relative to DMSO-treated control | Mus musculus | 5 | cell-based format | Scientific Literature | ||
4. | ALA3090684 | B | Inhibition of PTP1B (unknown origin) assessed as p-nitrophenol release from pNPP substrate after 30 mins by spectrophotometry | Homo sapiens | 15 | single protein format | Scientific Literature | ||
5. | ALA3539365 | A | Activity of recombinant human CYP2C9 expressed in Saccharomyces cerevisiae AH22 cells assessed as enzyme-mediated compound formation treated with (S)-episesamin monocatechol at 1 to 30 uM after 15 mins by HPLC analysis in presence of NADPH | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
6. | ALA3539366 | A | Activity of recombinant human CYP2C9 expressed in Saccharomyces cerevisiae AH22 cells assessed as enzyme-mediated compound formation treated with (R)-episesamin monocatechol at 1 to 30 uM after 15 mins by HPLC analysis in presence of NADPH | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
7. | ALA3539367 | A | Activity of recombinant human CYP1A2 expressed in Saccharomyces cerevisiae AH22 cells assessed as enzyme-mediated compound formation treated with (R)-episesamin monocatechol at 1 to 30 uM after 15 mins by HPLC analysis in presence of NADPH | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
8. | ALA3539368 | A | Activity of recombinant human CYP1A2 expressed in Saccharomyces cerevisiae AH22 cells assessed as enzyme-mediated compound formation treated with (S)-episesamin monocatechol at 1 to 30 uM after 15 mins by HPLC analysis in presence of NADPH | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
9. | ALA3537498 | A | Activity of recombinant human CYP2C19 expressed in Saccharomyces cerevisiae AH22 cells assessed as enzyme-mediated compound formation treated with episesamin at 2 to 75 uM after 15 mins by HPLC analysis in presence of NADPH | Homo sapiens | 3 | cell-based format | Scientific Literature |